REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$10.28
+3.11%
Mkt Cap $500.95M
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
Implied Upside
+86.2%
Consensus $19.14 vs current $10.28
NASDAQ·Healthcare·Biotechnology
$10.28
+3.11%
Mkt Cap $500.95M
Buy
11
Hold
1
Sell
0
Price Target (25 analysts)
$19.14
Range $12.00 – $32.00
+86.2%
Consensus $19.14 vs current $10.28